E-LIB Suche - Ergebnisse für: Colombel, F.

1

P104 Per- and poly-fluoroalkyl substances (PFAS) exposure i..:

Agrawal, M ; Midya, V ; Picker, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i386-i387 , 2024

Link: https://doi.org/10.1093/..

2

P741 Characterisation of endoscopic improvements with risan..:

Reinisch, W ; Colombel, J F ; Ma, C...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1388-i1389 , 2024

Link: https://doi.org/10.1093/..

3

OP18 Efficacy and safety of darvadstrocel treatment in pati..:

Serclova, Z ; Garcia-Olmo, D ; Chen, S T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i34-i35 , 2024

Link: https://doi.org/10.1093/..

4

P593 Efficacy of Risankizumab in Patients With Moderately t..:

Panaccione, R ; Louis, E ; Colombel, J F...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1153-i1155 , 2024

Link: https://doi.org/10.1093/..

5

P983 Treatment of patients with moderate-to-severe Crohn's ..:

Sands, B E ; Dubinsky, M C ; D'Haens, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1782-i1783 , 2024

Link: https://doi.org/10.1093/..

6

P420 Natural history of intra-abdominal inflammatory masses..:

Djalal, A ; Sehgal, P ; Shenoy, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i867-i868 , 2024

Link: https://doi.org/10.1093/..

7

DOP68 Natural history of isolated Crohn's Disease perianal ..:

Sangmo, L ; Quraishi, B ; Rajauria, P...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i196-i198 , 2024

Link: https://doi.org/10.1093/..

8

P1008 Efficacy and safety of retreatment with upadacitinib ..:

Panaccione, R ; Colombel, J F ; Dubinsky, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1821-i1822 , 2024

Link: https://doi.org/10.1093/..

9

P565 Capillary blood based self-collection device for infli..:

Law, C ; Djalal, A ; Hopkins, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1102-i1103 , 2024

Link: https://doi.org/10.1093/..

10

P439 Mild Crohn's disease is characterized by a unique seru..:

Bourgonje, A R ; Ibing, S ; Argmann, C...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i897-i898 , 2024

Link: https://doi.org/10.1093/..

11

P623 Network meta-analysis to evaluate the comparative effi..:

Schreiber, S W ; Danese, S ; Colombel, J F...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1198-i1199 , 2024

Link: https://doi.org/10.1093/..

12

DOP11 Disease clearance after 16 weeks of treatment with ve..:

Jairath, V ; Zou, G ; Adsul, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i92-i93 , 2024

Link: https://doi.org/10.1093/..

13

P409 Optimal endoscopic healing thresholds defined by MM-SE..:

Narula, N ; Wong, E C ; Dulai, P S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i847-i848 , 2024

Link: https://doi.org/10.1093/..

14

P766 No difference in progression of disability 2 years aft..:

Vieujean, S ; Desseaux, K ; Laharie, D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1429-i1431 , 2024

Link: https://doi.org/10.1093/..

15

OP39 Vedolizumab response in ulcerative colitis associates ..:

Canales-Herrerias, P ; Uzzan, M ; Al-taie, Z...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i69-i70 , 2024

Link: https://doi.org/10.1093/..